News Conference News CRT 2025 AGENT IDE: DCB Performance for In-Stent Restenosis Lasts Out to 2 Years L.A. McKeown March 10, 2025
News Conference News CRT 2024 Mixed Bag With DCBs for In-Stent Restenosis, Small Coronary Arteries L.A. McKeown March 14, 2024
News Conference News CRT 2024 Full AGENT IDE Results Affirm Benefits of DCB for In-Stent Restenosis L.A. McKeown March 09, 2024
News Conference News CRT 2020 Newer, Thinner-Strut Abbott Scaffold Prompts Talk of a BVS Comeback Michael O'Riordan February 28, 2020
News Conference News CRT 2019 SAFE-DCB Demonstrates Consistent Efficacy at 1 Year in Real-world Femoropopliteal Disease Patients Yael L. Maxwell March 14, 2019
News Conference News CRT 2019 ORBITA Absorbed: Principal Investigator Reflects on How Results Have Changed Her Practice Yael L. Maxwell March 07, 2019
News Conference News CRT 2019 Acknowledgment of Safety Signal for Paclitaxel Devices in PAD May Mark Sea Change in Controversy L.A. McKeown March 06, 2019
News Conference News CRT 2018 Time to Shine: ‘Historic’ All-Female Team Takes Over Live Case at CRT 2018 Michael O'Riordan March 06, 2018
News Conference News CRT 2016 Registry Behind TASTE Reopens Thrombus Aspiration Question With New Analysis of Stent Thrombosis Shelley Wood February 22, 2016